CCL

Összesen 20 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM116102
035-os BibID:(Scopus)85164401622 (WOS)001017815400001
Első szerző:Banach, Maciej
Cím:Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab : a subanalysis of the ODYSSEY APPRISE study / Banach Maciej, Lewek Joanna, Pol Kaja, Rabczenko Daniel, Balanescu Serban M., Blaha Vladimir, Ceska Richard, Jankowski Piotr, Surma Stanisaw, Kolovou Genovefa, Liberopoulos Evangelos, Mitu Florin, Mitu Magda, Naji Franjo Husam, Paragh Gyorgy, Popawska Magdalena, Vrablik Michal, Pella Daniel
Dátum:2023
ISSN:2297-055X
Megjegyzések:BackgroundDespite better accessibility of the effective lipid-lowering therapies, only about 20% of patients at very high cardiovascular risk achieve the low-density lipoprotein cholesterol (LDL-C) goals. There is a large disparity between European countries with worse results observed for the Central and Eastern Europe (CEE) patients. One of the main reasons for this ineffectiveness is therapeutic inertia related to the limited access to appropriate therapy and suitable dosage intensity. Thus, we aimed to compare the differences in physicians' therapeutic decisions on alirocumab dose selection, and factors affecting these in CEE countries vs. other countries included in the ODYSSEY APPRISE study.MethodsODYSSEY APPRISE was a prospective, single-arm, phase 3b open-label (& GE;12 weeks to & LE;30 months) study with alirocumab. Patients received 75 or 150 mg of alirocumab every 2 weeks, with dose adjustment during the study based on physician's judgment. The CEE group in the study included Czechia, Greece, Hungary, Poland, Romania, Slovakia, and Slovenia, which we compared with the other nine European countries (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Spain, and Switzerland) plus Canada.ResultsA total of 921 patients on alirocumab were involved [modified intention-to-treat (mITT) analysis], including 114 (12.4%) subjects from CEE countries. Therapy in CEE vs. other countries was numerically more frequently started with lower alirocumab dose (75 mg) at the first visit (74.6 vs. 68%, p = 0.16). Since week 36, the higher dose was predominantly used in CEE patients (150 mg dose in 51.6% patients), which was maintained by the end of the study. Altogether, alirocumab dose was significantly more often increased by CEE physicians (54.1 vs. 39.9%, p = 0.013). Therefore, more patients achieved LDL-C goal at the end of the study (<55 mg/dl/1.4 mmol/L and 50% reduction of LDL-C: 32.5% vs. 28.8%). The only factor significantly influencing the decision on dose of alirocumab was LDL-C level for both countries' groups (CEE: 199.2 vs. 175.3 mg/dl; p = 0.019; other: 205.9 vs. 171.6 mg/dl; p < 0.001, for 150 and 75 mg of alirocumab, respectively) which was also confirmed in multivariable analysis (OR = 1.10; 95% CI: 1.07-1.13).ConclusionsDespite larger unmet needs and regional disparities in LDL-C targets achievement in CEE countries, more physicians in this region tend to use the higher dose of alirocumab, they are more prone to increase the dose, which is associated with a higher proportion of patients reaching LDL-C goals. The only factor that significantly influences decision whether to increase or decrease the dose of alirocumab is LDL-C level.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Frontiers in Cardiovascular Medicine. - 10 (2023), p. 1-9. -
További szerzők:Lewek, Joanna Pol, Kaja Rabczenko, Daniel Balanescu, Serban M. Blaha, Vladimir Ceska, Richard Jankowski, Piotr Surma, Stanisaw Kolovou, Genovefa Liberopoulos, Evangelos Mitu, Florin Mitu, Magda Naji, Franjo Husam Paragh György (1953-) (belgyógyász) Popawska, Magdalena Vrablík, Michal Pella, Daniel
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM024435
Első szerző:Camps, Jordi
Cím:Paraoxonase-1 and clopidogrel efficacy / Jordi Camps, Jorge Joven, Bharti Mackness, Michael Mackness, Dan Tawfik, Dragomir Draganov, Lucio G. Costa, György Paragh, Ildikó Seres, Sven Horke, Richard James, Antonio Hernández, Srinivasa Reddy, Diana Shih, Mohamed Navab, Daniel Rochu, Michael Aviram
Dátum:2011
ISSN:1078-8956
Tárgyszavak:Orvostudományok Klinikai orvostudományok levél
Megjelenés:Nature Medicine. - 17 : 9 (2011), p. 1041-1042. -
További szerzők:Joven, Jorge Mackness, Bharti Mackness, Michael Tawfik, Dan Draganov, Dragomir Costa, Lucio G. Paragh György (1953-) (belgyógyász) Seres Ildikó (1954-) (biokémikus) Horke, Sven James, Richard Hernández, Antonio Reddy, Srinivasa Shih, Diana Navab, Mohamed Rochu, Daniel Aviram, Michael
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

3.

001-es BibID:BIBFORM107033
035-os BibID:(cikkazonosító)e1003121 (scopus)85088156256 (wos)000553974800004
Első szerző:Cicero, Arrigo F. G.
Cím:Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia : A systematic review and meta-analysis / Cicero Arrigo F. G., Fogacci Federica, Hernandez Adrian V., Banach Maciej, Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group, International Lipid Expert Panel (ILEP)
Dátum:2020
ISSN:1549-1676
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:PLOS Medicine. - 17 : 7 (2020), p. 1-21. -
További szerzők:Fogacci, Federica Hernandez, Adrian V. Banach, Maciej Paragh György (1953-) (belgyógyász) Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group International Lipid Expert Panel (ILEP)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM072211
035-os BibID:(cikkazonosító)4310816 (PMID)29743981 (PMCID)PMC5883980
Első szerző:Erdei Judit Zsuzsa (vegyész)
Cím:Induction Of NLRP3 Inflammasome Activation By Heme In Human Endothelial Cells / Judit Erdei, Andrea Tóth, Enikő Balogh, Benard Bogonko Nyakundi, Emese Bányai, Bernhard Ryffel, György Paragh, Mario D. Cordero, Viktória Jeney
Dátum:2018
ISSN:1942-0994 1942-0900
Megjegyzések:Hemolytic or hemorrhagic episodes are often associated with inflammation even when infectious agents are absent suggesting that red blood cells (RBCs) release damage-associated molecular patterns (DAMPs). DAMPs activate immune and nonimmune cells through pattern recognition receptors. Heme, released from RBCs, is a DAMP and induces IL-1β production through the activation of the nucleotide-binding domain and leucine-rich repeat-containing family and pyrin domain containing 3 (NLRP3) in macrophages; however, other cellular targets of heme-mediated inflammasome activation were not investigated. Because of their location, endothelial cells can be largely exposed to RBC-derived DAMPs; therefore, we investigated whether heme and other hemoglobin- (Hb-) derived species induce NLRP3 inflammasome activation in these cells. We found that heme upregulated NLRP3 expression and induced active IL-1β production in human umbilical vein endothelial cells (HUVECs). LPS priming largely amplified the heme-mediated production of IL-1β. Heme administration into C57BL/6 mice induced caspase-1 activation and cleavage of IL-1β which was not observed in NLRP3?/? mice. Unfettered production of reactive oxygen species played a critical role in heme-mediated NLRP3 activation. Activation of NLRP3 by heme required structural integrity of the heme molecule, as neither protoporphyrin IX nor iron-induced IL-1β production. Neither naive nor oxidized forms of Hb were able to induce IL-1β production in HUVECs. Our results identified endothelial cells as a target of heme-mediated NLRP3 activation that can contribute to the inflammation triggered by sterile hemolysis. Thus, understanding the characteristics and cellular counterparts of RBC-derived DAMPs might allow us to identify new therapeutic targets for hemolytic diseases.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Heme
endothelial cells
hemolysis
hemoglobin
DAMP
NLRP3 inflammasome activation
IL-1?
ROS
Megjelenés:Oxidative Medicine and Cellular Longevity. - 2018 (2018), p. 1-14. -
További szerzők:Tóth Andrea (1992-) (molekuláris biológus) Balogh Enikő (1987-) (molekuláris biológus) Nyakundi, Benard Bogonko (1983-) (biokémikus) Bányai Emese (1984-) (orvos) Ryffel, Bernhard Paragh György (1953-) (belgyógyász) Cordero, Mario D. Jeney Viktória (1971-) (vegyész, kémia tanár)
Pályázati támogatás:NKFIH K116024
Egyéb
GINOP-2.3.2-15-2016-00005
GINOP
Internet cím:Szerző által megadott URL
Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

5.

001-es BibID:BIBFORM051292
Első szerző:Fülöp Péter (belgyógyász, endokrinológus, lipidológus)
Cím:Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients / Péter Fülöp, Ildikó Seres, Hajnalka Lőrincz, Mariann Harangi, Sándor Somodi, György Paragh
Dátum:2014
ISSN:1582-1838
Megjegyzések:The prevalence of obesity has been increasing worldwide. Chemerin is a recently discovered adipokine secreted by the enlarged adipose tissue with diverse biological effects that are not well detailed yet. This study aimed to elucidate the potential role of chemerin in oxidative stress and inflammation that are characteristics for excess weight and may eventually lead to insulin resistance and atherosclerotic complications. We also analysed the associations between chemerin and classical adipokines, namely leptin and adiponectin. Therefore, we investigated non-diabetic obese patients without manifest cardiovascular disease and compared their data to healthy lean individuals. Chemerin correlated positively with markers of oxidative stress and inflammation, while it showed a negative correlation with the measure of antioxidant status, characterized by the HDL-linked paraoxonase-1 enzyme. Chemerin also correlated positively with leptin and negatively with adiponectin respectively. In our study population, oxidized low-density lipoprotein and high-sensitivity C-reactive protein were found to be the strongest predictors of chemerin level. We conclude that chemerin may contribute to chronic inflammation and increased oxidative stress in obese individuals, even in the absence of manifest insulin resistance.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Journal of Cellular and Molecular Medicine. - 18 : 7 (2014), p. 1313-1320. -
További szerzők:Seres Ildikó (1954-) (biokémikus) Lőrincz Hajnalka (1986-) (biológus) Harangi Mariann (1974-) (belgyógyász, endokrinológus) Somodi Sándor (1977-) (belgyógyász) Paragh György (1953-) (belgyógyász)
Pályázati támogatás:TÁMOP-4.2.2.A-11/1/KONV-2012-0031
TÁMOP
84196
OTKA
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

6.

001-es BibID:BIBFORM040826
Első szerző:Fülöp Péter (belgyógyász, endokrinológus, lipidológus)
Cím:Increased hair selenium concentration in hyperlipidemic patients / Péter Fülöp, Ildikó Seres, Zoltán Jenei, Imre Juhász, György Paragh
Dátum:2013
ISSN:1582-1838
Megjegyzések:Selenium is an essential trace element with potential anti-atherogenic and antioxidant effects. Experimental data suggest that selenium might be beneficial in the prevention of atherosclerosis and its complications, whereas human epidemiological studies have yielded conflicting results. Data on hair selenium status in hyperlipidemic patients are still lacking. Therefore, we analysed selenium concentrations by X-ray fluorescence in the hair of 81 statin-naïve patients with newly diagnosed Fredrickson-type IIa and IIb hyperlipoproteinemia and compared their data with 43 healthy volunteers. We also assessed the frequency of other classical risk factors of atherosclerosis. Hair selenium levels were found to be significantly higher in hyperlipidemic patients compared with volunteers with normal lipid levels. Also, a significantly increased number of traditional atherosclerosis risk factors were observed in hyperlipidemic patients with hair selenium concentrations above the median in contrast to those with below. Our results suggest that high hair selenium status might be associated with adverse blood lipid profile together with an increased number of traditional risk factors in a selenium-deplete population. These findings warrant further investigations to study the impact of selenium supplementation on the incidence of cardiovascular events.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Egészség- és Környezettudomány
Megjelenés:Journal of Cellular and Molecular Medicine. - 17 : 3 (2013), p. 350-355. -
További szerzők:Seres Ildikó (1954-) (biokémikus) Jenei Zoltán (1968-) (belgyógyász) Juhász Imre (1986-) (belgyógyász) Paragh György (1953-) (belgyógyász)
Pályázati támogatás:TÁMOP-4.2.1/B-09/1/KONV-2010-0007
TÁMOP
Gyulladásos és egyéb proatherogén tényezők vizsgálata a lipidanyagcsere zavarával járó kórállapotokban
TÁMOP-4.2.2/B-10/1-2010-0024
TÁMOP
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

7.

001-es BibID:BIBFORM014708
Első szerző:Harangi Mariann (belgyógyász, endokrinológus)
Cím:High-Speed Detection of the Two Common Paraoxonase Polymorphisms Leu55 -> Met and Gln192 -> Arg by Real-Time Fluorescence PCR and Melting Curves / Harangi Mariann, Aslanidis Charalampos, Paragh György, Schmitz Gerd
Dátum:2002
ISSN:1434-6621
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
Megjelenés:Clinical Chemistry And Laboratory Medicine. - 40 : 4 (2002), p. 337-340. -
További szerzők:Aslanidis, Charalampos Paragh György (1953-) (belgyógyász) Schmitz, Gerd
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

8.

001-es BibID:BIBFORM104481
035-os BibID:(scopus)85140565208 (cikkazonosító)e31035
Első szerző:Horváth Judit (orvos)
Cím:Effectiveness of hospital-based low intensity and inspected aerobic training on functionality and cardiorespiratory fitness in unconditioned stroke patients : Importance of submaximal aerobic fitness markers / Judit Horváth, Adél Debreceni Nagy, Péter Fülöp, Zoltán Jenei
Dátum:2022
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Medicine. - 101 : 42 (2022), p. 1-6. -
További szerzők:Debreceni Nagy Adél Fülöp Péter (1974-) (belgyógyász, endokrinológus, lipidológus) Jenei Zoltán (1968-) (belgyógyász)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

9.

001-es BibID:BIBFORM101051
035-os BibID:(cikkazonosító)8543232
Első szerző:Juhász Imre (belgyógyász)
Cím:The Potential Diagnostic and Predictive Role of HbA1c in Diabetic, Septic Patients : a Retrospective Single-Center Study / Juhász Imre, Juhász Janka, Lörincz Hajnalka, Seres Ildikó, Végh Lilla, Ujfalusi Szilvia, Harangi Mariann, Szabó Zoltán, Paragh György
Dátum:2022
ISSN:2090-2840 2090-2859
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Emergency Medicine International. - 2022 (2022), p. 1-11. -
További szerzők:Juhász Janka Lőrincz Hajnalka (1986-) (biológus) Seres Ildikó (1954-) (biokémikus) Végh Lilla Ujfalusi Szilvia (1990-) (belgyógyász) Harangi Mariann (1974-) (belgyógyász, endokrinológus) Szabó Zoltán (1973-) (belgyógyász, kardiológus) Paragh György (1953-) (belgyógyász)
Pályázati támogatás:NKFIH K115723
Egyéb
GINOP-2.3.2-15-2016-00005
GINOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

10.

001-es BibID:BIBFORM010188
Első szerző:Káplár Miklós (belgyógyász, diabetológus)
Cím:Changes in cerebral blood flow detected by SPECT in type 1 and type 2 diabetic patients / Káplár Miklós, Paragh György, Erdei Annamária, Csongrádi Éva, Varga Éva, Garai Ildikó, Szabados Lajos, Galuska László, Varga József
Dátum:2009
ISSN:0161-5505 (Print)
Megjegyzések:Although macrovascular complications are typical for type 2 diabetes mellitus (T2DM), cerebral microvascular damage develops both in type 1 diabetes mellitus (T1DM) and T2DM. Color Doppler ultrasound is widely used for the examination of large- and medium-sized arteries, whereas SPECT and MRI are capable of identifying disturbances in the circulation of microvessels. Former studies using semiquantitative methods showed reduced reactivity and reserve capacity of cerebral vessels in both T1DM and T2DM patients. Our aim was to investigate whether there was any difference in the effects of the 2 types of diabetes mellitus on the global or regional cerebral blood flow, influenced by microvascular damage. METHODS: In our study, the circulation and reserve capacity of cerebral arteries was examined using (99m)Tc-hexamethylpropylene amine oxime SPECT. A total of 17 individuals with T1DM and 43 individuals with T2DM were involved in the study. RESULTS: Both basal and acetazolamide-challenged brain circulation were significantly lower in T2DM patients than in T1DM patients. We did not find a significant difference in the reserve capacity. However, the circulation of the frontal and occipital lobes changed differently in the 2 groups. The ratio of the circulation of the frontal and occipital lobes was significantly reduced both in basal and in acetazolamide-stimulated states in T2DM patients, independently of age (P < 0.0005 and P < 0.017), showing a greater relative decrease in the circulation of the frontal lobe in T2DM patients. CONCLUSION: There was a significant association between basal brain circulation and age, body mass index, and high-density lipoprotein (HDL), whereas acetazolamide-stimulated circulation showed a significant association with serum triglyceride and HDL.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
Megjelenés:Journal of Nuclear Medicine. - 50 : 12 (2009), p. 1993-1998. -
További szerzők:Paragh György (1953-) (belgyógyász) Erdei Annamária (1976-) (belgyógyász) Csongrádi Éva (1969-) (szakorvos) Varga Éva (1982-) (belgyógyász) Garai Ildikó (1966-) (radiológus) Szabados Lajos (1977-) (orvos) Galuska László (1946-) (belgyógyász, izotópdiagnoszta) Varga József (1955-) (fizikus)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

11.

001-es BibID:BIBFORM087278
035-os BibID:(WoS)000492444403175
Első szerző:Képes Zita (orvos)
Cím:Examinantion of brain perfusion and metabolism in metabolic diseases (focusing on diabetes and obesity) / Zita Képes, J. Varga, F. Nagy, M. Emri, M. Káplár, Cs. Aranyi, I. Garai
Dátum:2019
ISSN:1619-7070 1619-7089
Megjegyzések:Aim/Introduction: Microcircular alterations that could already be observed in prediabetic state (obesity and insulin resistance) are supposed to have significant role in the developement of the consequences of diabetes mellitus. The main aim of our study was to compare the cerebrovascular microcirculation and metabolism of obese patients and patients suffering from type 2 diabetes mellitus. Materials and Methods: In our prospective study 57 patients with controlled type 2 diabetes mellitus (52?9,6 years) and 46 obese patients (50,6?7,9 years) were enrolled. BMI proved to be 34,06?5,94 in the diabetic group while it was 38,14?6,06 among the obese patients. Dynamic Tc99m-HMPAO study (AnyScanFlex, Mediso) was performed for evaluation of hemispheral perfusion using Patlak analysis. Then tomographic imaging was carried out at rest condition. Brain metabolism was estimated applying 18F-FDG PET/CT (AnyScan PC, Mediso). FDG and HMPAO scans were transformed to MNI152 brain map after T1 registration and used for SPM (Statistical Parametric Mapping) analysis. NeuroQ application (Syntermed) was used to evaluate regional differences. Statistical analysis (Shapiro-Wilk, Wilcoxon, Spearman correlation) was applied for assessment of group differences. Results: Hemispheral perfusion calculated with Patlak analysis showed positive correlation with BMI (rho=0.35, p=0.016). There were no significant differences in hemispheral and regional perfusion in T2DM and the obese group. However, we found hypometabolism in right and left cuneus (Br17) in T2DM with SPM analysis. NeuroQ analysis did not reveal significant regional perfusion or metabolic defects in either groups. Conclusion: Based on current literature hypometabolism in the region of the cuneus is a characteristic feature of neurodegenerative diseases. The reason why no significant perfusion defects were found could be explained by the fact that the enrolled diabetics were therapeutically well managed. Unexpected significant correlation with BMI is unclear, further investigation is required. References: None
Tárgyszavak:Orvostudományok Klinikai orvostudományok idézhető absztrakt
folyóiratcikk
Megjelenés:European Journal of Nuclear Medicine and Molecular Imaging. - 46 : S1 (2019), p. S399-S400. -
További szerzők:Varga József (1955-) (fizikus) Nagy Ferenc (1984-) (fizikus) Emri Miklós (1962-) (fizikus) Káplár Miklós (1965-) (belgyógyász, diabetológus) Aranyi Sándor Csaba (1988-) (programtervező informatikus) Garai Ildikó (1966-) (radiológus)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

12.

001-es BibID:BIBFORM106314
035-os BibID:(cikkazonosító)1081986 (Scopus)85146987410 (WoS)000917668200001
Első szerző:Kovács Beáta (belgyógyász)
Cím:Determining the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods in the Northeastern region of Hungary / Beáta Kovács, Ákos Németh, Bálint Daróczy, Zsolt Karányi, László Maroda, Ágnes Diószegi, Bíborka Nádró, Tamás Szabó, Mariann Harangi, Dénes Páll
Dátum:2023
ISSN:2297-055X
Megjegyzések:Objective: Identifying hypertension in children and providing treatment for it have a marked impact on the patients' long-term cardiovascular outcomes. The global prevalence of childhood hypertension is increasing, yet its investigation has been rather sporadic in Eastern Europe. Therefore, our goal was to determine the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods. Methods: We evaluated data from 3 to 18-year-old children who visited the University of Debrecen Clinical Center's hospital throughout a 15-year study period (n = 92,198; boys/girls: 48/52%). Results: We identified a total of 3,687 children with hypertension (2,107 boys and 1,580 girls), with a 4% calculated prevalence of hypertension in the whole study population and a higher prevalence in boys (4.7%) as compared to girls (3.2%). Among boys we found an increasing prevalence in consecutive age groups in the study population, but among girls the highest prevalences are identified in the 12-15-year age group. Markedly higher BMI values were found in hypertensive children as compared to non-hypertensives in all age groups. Moreover, significantly higher total cholesterol (4.27 ? 0.95 vs. 4.17 ? 0.88 mmol/L), LDL-C (2.62 ? 0.79 vs. 2.44 ? 0.74 mmol/L) and triglyceride (1.2 (0.85-1.69) vs. 0.94 (0.7-1.33) mmol/L), and lower HDL-C (1.2 ? 0.3 vs. 1.42 ? 0.39 mmol/L) levels were found in hypertensive children. Furthermore, significantly higher serum uric acid levels were found in children with hypertension (299.2 ? 86.1 vs. 259.9 ? 73.3 ?mol/L), while glucose levels did not differ significantly. Conclusion: Our data suggest that the calculated prevalence of childhood hypertension in our region is comparable to data from other European countries and is associated with early metabolic disturbances. Data mining is an effective method for identifying childhood hypertension and its metabolic consequences.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
adolescents
blood pressure
children
data mining
hypertension
metabolic parameters
obesity
prevalence
Megjelenés:Frontiers in Cardiovascular Medicine. - 9 (2023), p. 1-10. -
További szerzők:Németh Ákos (1984-) (gyógyszer-vegyészmérnök, közgazdász) Daróczy Bálint (1984-) (informatikus, matematikus) Karányi Zsolt (1961-) (biostatisztikus, bioinformatikus) Maroda László (1979-) (gyógyszerész) Diószegi Ágnes (1987-) (belgyógyász) Nádró Bíborka (1992-) (általános orvos) Szabó Tamás (1968-) (gyermekgyógyász) Harangi Mariann (1974-) (belgyógyász, endokrinológus) Páll Dénes (1967-) (belgyógyász, kardiológus)
Pályázati támogatás:K142273
OTKA
MTA Premium Postdoctoral Fund
MTA
European Union Project RRF-2.3.1-21-2022-00004
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 2 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.